Condition deep-dive · 6 min read

Tinnitus supplement protocol — what the evidence supports (and doesn't)

Updated 2026-05-10 · Reviewed by SupplementScore editors · No sponsorships

Tinnitus is one of the most heavily marketed supplement spaces and one of the most evidence-poor. The AAO-HNS clinical practice guideline (Tunkel 2014, updated since) explicitly recommends against routine ginkgo biloba, melatonin, zinc, and "dietary supplements" for chronic primary tinnitus on the basis of insufficient evidence — except where a specific deficiency (zinc, B12) is documented. This page covers the few interventions where evidence does support a trial, and the much longer list of marketing claims that don't hold up.

Read this first. New-onset tinnitus, particularly unilateral or pulsatile tinnitus, deserves urgent ENT evaluation — vascular causes, vestibular schwannoma, and serous otitis among others have specific workups. Several common medications cause or worsen tinnitus (high-dose aspirin and other NSAIDs, certain antibiotics, loop diuretics, some chemotherapies); medication review with your prescriber should precede any supplement protocol.

Where the evidence does support a trial

Tier 2 evidence · Tinnitus in zinc-deficient patients

Zinc (in confirmed deficiency only)

25–50 mg elemental zinc daily for 8–12 weeks; pair with copper 1–2 mg if extending past 12 weeks

Routine zinc supplementation in zinc-replete patients does not help tinnitus. In patients with documented low serum zinc (often associated with older age or specific dietary patterns), correction of deficiency has shown modest reductions in tinnitus loudness and impact in small RCTs. Test serum zinc; supplement only if low. Above 40 mg/day chronically, pair with copper to prevent copper deficiency.

Tier 2 evidence · Tinnitus in B12-deficient patients

Methylcobalamin (in confirmed B12 deficiency)

1000 mcg sublingual or oral daily; or IM injection per primary care

Tinnitus has been associated with B12 deficiency in observational studies, and case series suggest improvement with B12 repletion in deficient patients. Test B12 (and methylmalonic acid if borderline); supplement only if low. The intervention here is treatment of B12 deficiency, not a "B12 for tinnitus" protocol.

Tier 3 evidence · Mixed signals; AAO-HNS does not recommend

Ginkgo biloba (EGb 761, standardised extract)

120–240 mg/day standardised extract

The most-trialled supplement for tinnitus and a perennial top seller. Cochrane reviews and the AAO-HNS guideline conclude that the evidence does not support routine use for chronic primary tinnitus. Some small trials in specific populations (cerebrovascular tinnitus, recent onset) show modest benefit; the trials are heterogeneous in extract quality, dose, duration, and patient selection. If trialled, use a standardised EGb 761 preparation rather than generic ginkgo for at least 12 weeks. Discuss with prescriber if on anticoagulants — additive bleeding risk.

The hearing-protection and exposure-reduction layer

The most predictable factors in tinnitus severity are noise exposure and hearing status. The supplement layer cannot substitute for:

Hearing aids in confirmed hearing loss — appropriately fitted hearing aids substantially reduce tinnitus burden in patients with concurrent hearing loss (which is most patients with chronic tinnitus).
Cognitive behavioural therapy (CBT) for tinnitus — has the best non-device evidence for reducing tinnitus distress and improving function. Internet-based CBT programmes are increasingly available.
Sound therapy / masking — bedside white-noise generators, fan, or hearing-aid masking features at sleep onset can substantially reduce tinnitus impact during the most vulnerable time of day.
Reducing ototoxic and noise exposures — review medications, use ear protection in loud environments.

The sleep-supportive layer

Tinnitus most commonly causes distress at sleep onset. Sleep-supportive options that are not specific to tinnitus but commonly help:

Magnesium glycinate 300–400 mg evenings — for sleep onset and maintenance.
L-Theanine 200 mg at bedtime — for the racing-mind sleep onset pattern.
Melatonin 0.3–3 mg 30–60 minutes pre-bedtime — Cochrane review of melatonin for tinnitus is not supportive of a tinnitus-specific effect, but melatonin may help sleep onset in patients whose distress disrupts it.

What to skip

"Tinnitus relief" combination products / drops — direct-to-consumer products marketed under names like "Lipo-Flavonoid," "Tinnitus911," and similar typically combine sub-therapeutic doses of multiple ingredients with marketing that overstates the evidence. The category is also a frequent target of regulatory action for misleading claims.
Generic ginkgo (not EGb 761) — what trials there are have used standardised extracts; generic preparations vary widely.
High-dose vitamin B6 — chronic doses above 100 mg/day can cause sensory neuropathy; some "tinnitus B-complex" products hide higher B6 doses.
Mega-dose vitamin C / antioxidant blends — no tinnitus-specific evidence.
"Stem cell" or "nerve repair" supplements marketed for tinnitus — not supported by clinical trial evidence.
CBD products marketed for tinnitus — limited tinnitus-specific evidence; product variability; drug-interaction footprint.

What to track

The Tinnitus Functional Index (TFI) and the Tinnitus Handicap Inventory (THI) are validated tinnitus impact scales suitable for self-administration. A clinically meaningful change is typically a 13-point reduction on the TFI. Pair tracking with a sleep diary if sleep onset is the dominant complaint. Reassess at 12 weeks of any supplement intervention. If no change at 12 weeks of consistent use, the supplement is not going to start working at 24 weeks.

Practical quick-start. Get an audiology assessment and consider hearing aids if hearing loss is present (this is the highest-yield single intervention). Review medications with your prescriber. Test serum zinc and B12; supplement only if low. Add CBT-based tinnitus retraining and bedtime sound masking. The supplement layer is the smallest, not the largest, part of the right approach.